REVIVAL
DEAD

Serial Number

79297218

Owner

AM-Pharma B.V.

Attorney

Krista Weber Powell

Filing Date

May 25, 2020

Add to watchlist:

No watchlists yet
View on USPTO

REVIVAL Trademark

Serial Number: 79297218

REVIVAL is a trademark filed by AM-Pharma B.V. on May 25, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

AM-Pharma B.V. (5 trademarks)

Stadsplateau 6
NL-3521 AZ Utrecht , NL

Entity Type: 16

Trademark Details

Filing Date

May 25, 2020

Registration Date

Not Registered

Goods & Services

Pharmaceutical and medical preparations for the treatment of infectious diseases, inflammatory diseases, kidney diseases, deficiency diseases; diagnostic preparations for medical use; enzyme preparations for medical use; medicines for human use for the treatment of infectious diseases; inflammatory diseases, kidney diseases, deficiency diseases; pharmaceutical drugs for the treatment of inflammatory diseases, kidney diseases, deficiency diseases, infectious diseases; pharmaceutical preparations for the treatment of kidney diseases and disorders

Scientific and technological services, namely, research and design in the field of computer datacenter architecture; scientific, technological and industrial research, namely scientific research, analysis, and reporting in the field of medicine and pharmaceutical preparations for the treatment of infectious diseases, inflammatory diseases, kidney diseases, deficiency diseases, autoimmune diseases; industrial analysis and industrial research in the field of medicine and drug development for treating infectious diseases, inflammatory diseases, kidney diseases, deficiency diseases; product development of technologies, diagnostics, pharmaceuticals, biotechnological research related to enzymatic synthesis; testing, authentication and quality control of pharmaceuticals for others; medical and pharmaceutical research services; provision of medical and scientific research information in the field of pharmaceutical products and clinical trials; drug research services; research and development services for the pharmaceutical and biotechnology industry; pharmaceutical drug development services; pharmaceutical product testing; development of pharmaceutical preparations and drugs; consultancy in the field of pharmaceutical research; clinical and medical research; scientific research for medical purposes, namely conducting clinical trials for others; conducting clinical trials for pharmaceutical products for others

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 12, 2023 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Oct 20, 2023 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 20, 2023 FICR
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Oct 20, 2022 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Oct 20, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 20, 2022 ABN2
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 24, 2022 OPNX
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 7, 2022 GNFN
FINAL REFUSAL E-MAILED
Apr 7, 2022 GNFR
FINAL REFUSAL WRITTEN
Apr 7, 2022 CNFR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 6, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 6, 2022 OPNR
ASSIGNED TO EXAMINER
Jan 10, 2022 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
May 27, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 27, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 27, 2021 TROA
REFUSAL PROCESSED BY IB
Dec 20, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 29, 2020 RFCS
REFUSAL PROCESSED BY MPU
Nov 29, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 11, 2020 RFCR
NON-FINAL ACTION WRITTEN
Nov 10, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 10, 2020 MAFR
ASSIGNED TO EXAMINER
Nov 6, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 6, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 5, 2020 REPR